Clinical Trials in Boston

Showing 12321-12340 of 15,299 trials

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder

NCT00120250

The purpose of this study is to obtain data investigating the safety and efficacy of eszopiclone for the treatment of post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with eszopiclone treatment on neuroendocrine correlates of PTSD. The investigators hypothesize that eszopiclone will be significantly more effective than placebo and well tolerated for PTSD-related sleep disturbance, improvement in sleep will be associated with improvement in overall PTSD symptoms, and patients with PTSD-related sleep disturbances will have abnormal levels of stress hormones.

Post-Traumatic Stress Disorders

Massachusetts General Hospital27 participantsStarted Jun 2005

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue

NCT02565823

The purpose of this study is to find out whether exercise leads to changes in the blood that are produced by exercised muscles and if these changes produce new hormones that affect the body's regulation of sugar and body weight.

Healthy

Joslin Diabetes Center12 participantsStarted Oct 2015

Boston, Massachusetts, United States

COMPLETEDPhase 2/3< 1 mile

Estrogen, HDL, and Coronary Heart Disease in Women

NCT00083824

To clarify the effects of estrogen, with or without progestin, on high density lipoprotein (HDL) in postmenopausal women.

Cardiovascular DiseasesCoronary DiseaseHeart Diseases+1 more

Tufts University309 participantsStarted Mar 2004

Boston, Massachusetts, United States

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder

The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue

Estrogen, HDL, and Coronary Heart Disease in Women

Find Trials by Condition in Boston

Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea

CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia

Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction

Relaxation Response Training to Treat Hypertension

AMG 595 First-in-Human in Recurrent Gliomas

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

Dose Comparison Study of Menactra® in US Children

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

The Drug Induced Renal Injury Consortium

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia